Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Jubilant Life Sciences Limited, once a prominent integrated global pharmaceutical and life sciences company, is now primarily recognised for its transformed entities. Headquartered in Noida, India, as part of the Jubilant Bhartia Group established in 1978, its core pharmaceutical preparation manufacturing businesses now operate under Jubilant Pharmova Limited, with a significant global footprint across North America, Europe, and India.
Jubilant Pharmova, the successor entity, excels in active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, and allergy therapy products. It is also a key global provider of contract manufacturing and development services (CDMO), leveraging extensive capabilities to deliver innovative solutions and contribute substantially to worldwide healthcare.
+7 vs industry average
Jubilant Life Sciences’s score of 49 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Jubilant Life Sciences, an India-headquartered Pharmaceutical Preparation Manufacturing company, reported its Scope 1 emissions at approximately 10,084,000 kg CO2e, Scope 2 emissions at about 64,219,000 kg CO2e, and Scope 3 emissions at approximately 527,407,000 kg CO2e for 2025.
Looking back, in 2024, the company's Scope 1 emissions were around 8,620,000 kg CO2e, Scope 2 emissions were approximately 68,152,000 kg CO2e, and Scope 3 emissions totalled about 737,234,000 kg CO2e. For 2023, Jubilant Life Sciences recorded Scope 1 emissions of approximately 8,492,000 kg CO2e, Scope 2 emissions of about 54,703,000 kg CO2e, and Scope 3 emissions of approximately 662,296,000 kg CO2e.
The company has set a long-term climate commitment to achieve net-zero Scope 1 emissions by 2050 and net-zero Scope 2 emissions by 2050.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more